`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
`Petitioner,
`v.
`
`GENENTECH, INC.
`Patent Owner
`
`
`
`Inter Partes Review No. IPR2017-02031
`
`PETITIONER BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.’S
`POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. 42.10(b), Petitioner Boehringer Ingelheim
`
`Pharmaceuticals, Inc. hereby appoints the following practitioners associated with
`
`Goodwin Procter LLP as its attorneys to transact all business in the United States
`
`Patent and Trademark Office associated with the above-captioned inter partes
`
`review of U.S. Patent No. 6,407,213:
`
`
`
`Ira J. Levy (lead counsel, Reg. No.
`35,587)
`GOODWIN PROCTER LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018-1405
`Tel: 212-813-8800
`Fax: 212-355-3333
`ilevy@goodwinlaw.com
`
`Brian A. Fairchild (backup counsel,
`Reg. No. 48,645)
`GOODWIN PROCTER LLP
`100 Northern Avenue
`Boston, MA 02210
`Tel: 617-570-1000
`Fax: 617-523-1231
`bfairchild@goodwinlaw.com
`
`
`
`
`
`
`
`
`
`
`Boehringer
`is empowered to act on behalf of Petitioner
`The undersigned
`
`Ingelheim Pharmaceuticals,
`Inc.
`By: �g�
`Name: M�rc A Be<i}Ct-1
`Title: \/ f-IP
`Date: 9/sJ/d.ot7
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that on this 31st day of August,
`
`2017, I caused to be served a true and correct copy of the foregoing
`
`“PETITIONER BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.’S
`
`POWER OF ATTORNEY” by Federal Express Next Business Day Delivery on
`
`the Patent Owner and its representatives at the below addresses:
`
`Genentech, Inc.
`Wendy M. Lee
`1 DNA Way
`South San Francisco, CA 94080
`
`
`
`
`By: /Sarah Fink/
`Sarah Fink
`
`
`
`